Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing ...

Illumina (ILMN) just deepened its bet on clinical whole genome sequencing by investing in and partnering with MyOme, backing a large Proactive Health trial that blends sequencing with AI driven risk ...

Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...

Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ban. The $1.08 billion it brought in for the third quarter was, however, ...

Revenue: $1.08 billion, roughly flat year-over-year, exceeded guidance range. Non-GAAP Operating Margin: 24.5%, expanded by 190 basis points year-over-year. Non-GAAP Diluted EPS: $1.34, grew $0.20 ...

Illumina announced today it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, for up to $425 ...

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego-based ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country. It’s part ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...

(2) Experts said that this matter will promote the development and accelerated penetration of China's sequencing product market, and popularize consumer-grade low-cost sequencing products. Finance ...

Illumina and next-gen sequencing (NGS) are synonymous. But to anyone paying attention, the company’s recent emphasis on multiomics has been hard to miss. Indeed, the company has launched both ...